< Back to all Breaking News
RXII
6/21/2017 07:06am
RXi Pharmaceuticals completes enrollment of RXI-109 Phase 1/2 clinical trial 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
